evans blue has been researched along with iberiotoxin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, HF; Lo, YC; Wu, SN | 1 |
| Chiang, HT; Wu, SN | 1 |
2 other study(ies) available for evans blue and iberiotoxin
| Article | Year |
|---|---|
Characterization of tetrandrine-induced inhibition of large-conductance calcium-activated potassium channels in a human endothelial cell line (HUV-EC-C).
Topics: Alkaloids; Apamin; Benzylisoquinolines; Calcium; Calcium Channel Blockers; Cell Line; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; Evans Blue; Glyburide; Humans; Membrane Potentials; Niflumic Acid; Nitroprusside; Peptides; Potassium Channels; Thapsigargin; Umbilical Veins | 2000 |
Inhibition of large-conductance calcium-activated potassium channel by 2-methoxyestradiol in cultured vascular endothelial (HUV-EC-C) cells.
Topics: 2-Methoxyestradiol; 8-Bromo Cyclic Adenosine Monophosphate; Cell Line; Diazoxide; Drug Interactions; Endothelium, Vascular; Estradiol; Estriol; Evans Blue; Humans; Indoles; Large-Conductance Calcium-Activated Potassium Channels; Membrane Potentials; Niflumic Acid; Patch-Clamp Techniques; Peptides; Potassium; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Vasodilator Agents | 2001 |